13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-13, with 31 holding rows worth $1,068,381,973.
- Accession
- 0001534261-19-000010
- Filer
- CIK 1534261
- Filed
- 2019-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 31 entries on the cover page, a total value of $1,068,381,973 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,068,381,974 with VALUE read as dollars, detected, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPARK THERAPEUTICS INC | 84652J103 | COM | 884,800 | $90,585,824 | dollars, detected | |
| INVITAE CORP | 46185L103 | COM | 3,838,388 | $90,202,118 | dollars, detected | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 940,000 | $88,670,200 | dollars, detected | |
| CODEXIS INC | 192005106 | COM | 5,073,780 | $86,519,885 | dollars, detected | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 400,000 | $73,236,000 | dollars, detected | |
| MYOKARDIA INC | 62857M105 | COM | 1,285,000 | $64,429,900 | dollars, detected | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,550,000 | $51,765,000 | dollars, detected | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 335,000 | $50,903,250 | dollars, detected | |
| BLUEBIRD BIO INC | 09609G100 | COM | 372,500 | $47,382,000 | dollars, detected | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 650,000 | $47,164,000 | dollars, detected | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 3,003,121 | $44,296,035 | dollars, detected | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 2,428,571 | $39,408,375 | dollars, detected | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 965,000 | $36,534,900 | dollars, detected | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 1,128,075 | $30,706,202 | dollars, detected | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 495,000 | $24,690,600 | dollars, detected | |
| ILLUMINA INC | 452327109 | COM | 60,000 | $22,089,000 | dollars, detected | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 3,365,000 | $21,838,850 | dollars, detected | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 463,125 | $20,100,347 | dollars, detected | |
| GRITSTONE BIO INC | 39868T105 | COM | 1,770,000 | $19,717,800 | dollars, detected | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,523,960 | $18,714,229 | dollars, detected | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,530,000 | $16,478,100 | dollars, detected | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 300,000 | $15,780,000 | dollars, detected | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 745,000 | $14,579,650 | dollars, detected | |
| EDITAS MEDICINE INC | 28106W103 | COM | 480,000 | $11,875,200 | dollars, detected | |
| ALECTOR INC | 014442107 | COMMON STOCK | 551,039 | $10,189,059 | dollars, detected | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 300,000 | $8,703,000 | dollars, detected | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 400,000 | $8,304,000 | dollars, detected | |
| CAREDX INC | 14167L103 | COM | 200,000 | $7,198,000 | dollars, detected | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 85,000 | $2,479,450 | dollars, detected | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 60,000 | $2,442,000 | dollars, detected | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 100,000 | $1,399,000 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001534261-19-000010 | this filing | 2019-08-13 | acceptance time not in the bulk data set |